Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TVMR With the INNOVALVE System Trial - Early Feasibility Study

NCT04919980 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT04919980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04919980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TVMR With the INNOVALVE System Trial - Early Feasibility Study
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2022
Completion date
July 1, 2034
Enrollment
85 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve regurgitation (degenerative or functional)